M. Webb

Epidemiology · with Brazowski · 2009

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Webb trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. E. Brunt
  2. Z. Younossi

Papers from M. Webb's perspective

Ordered by how strongly the researchers M. Webb trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. (Gastroenterology)
  2. Nonalcoholic Steatohepatitis: Definition and Pathology (Seminars in liver disease (Print))
  3. The utility of radiological imaging in nonalcoholic fatty liver disease. (Gastroenterology)
  4. Nonalcoholic steatohepatitis (Current treatment options in gastroenterology)
  5. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality (Hepatology)
  6. ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
  7. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. (The Lancet)
  8. NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States (Hepatology)
  9. A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease (American Journal of Gastroenterology)
  10. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)

Their papers